相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma
Mengge Li et al.
HEPATOLOGY RESEARCH (2021)
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only Multicenter Propensity Score-matched Analysis
Lilly J. H. Brada et al.
ANNALS OF SURGERY (2021)
Comparison of ICC patients with hepatitis B infection to those with no major risk factors for HCC
Kwang Min Kim et al.
HPB (2021)
Cholangiocarcinoma
Paul J. Brindley et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
Oliver Clements et al.
JOURNAL OF HEPATOLOGY (2020)
The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
Qiao Ke et al.
PLOS ONE (2020)
Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study
Lei Wang et al.
CANCER MEDICINE (2020)
Hepatitis B virus infection and the risk of cancer among the Chinese population
Ting Tian et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?
Ariella M. Altman et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
Alphonse E. Sirica et al.
HEPATOLOGY (2019)
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Rachna T. Shroff et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Surgery for cholangiocarcinoma
Umberto Cillo et al.
LIVER INTERNATIONAL (2019)
Cholangiocarcinoma: Epidemiology and risk factors
Shahid A. Khan et al.
LIVER INTERNATIONAL (2019)
Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials
Carlo Messina et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study
Xu-Feng Zhang et al.
WORLD JOURNAL OF SURGERY (2018)
Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric
Wei-Wen Chang et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma
Hiroya Iida et al.
WORLD JOURNAL OF SURGERY (2017)
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Seogsong Jeong et al.
ONCOTARGET (2017)
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Nader N. Massarweh et al.
CANCER CONTROL (2017)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare
Jessica L. Petrick et al.
PLOS ONE (2017)
Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis
Qing Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
Agrin Moeini et al.
CLINICAL CANCER RESEARCH (2016)
Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management
Han Zhang et al.
CANCER LETTERS (2016)
Adjuvant therapy for resected biliary tract cancer: a review
Mark K. Doherty et al.
CHINESE CLINICAL ONCOLOGY (2016)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Temporal Trends in Liver-Directed Therapy of Patients With Intrahepatic Cholangiocarcinoma in the United States: A Population-Based Analysis
Neda Amini et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Outcomes in Biliary Malignancy
Bas Groot Koerkamp et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Defining the Role of Adjuvant Therapy: Cholangiocarcinoma and Gall Bladder Cancer
Terence M. Williams et al.
SEMINARS IN RADIATION ONCOLOGY (2014)
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
Mina Komuta et al.
HEPATOLOGY (2012)
Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus
Ning-fu Peng et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Hepatitis B virus infection: A favorable prognostic factor for intrahepatic cholangiocarcinoma after resection
Hua-Bang Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis
HuaBang Zhou et al.
EUROPEAN JOURNAL OF CANCER (2010)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China
Lian-Yuan Tao et al.
LIVER INTERNATIONAL (2010)
Multiepitope Peptide-Loaded Virus-Like Particles as a Vaccine Against Hepatitis B Virus-Related Hepatocellular Carcinoma
Fei-Xiang Ding et al.
HEPATOLOGY (2009)
分享论文
